Kinetics of Enzyme Action – Essential Principles for Drug Hunters
Autor RL Steinen Limba Engleză Hardback – 4 aug 2011
Preț: 679.89 lei
Preț vechi: 715.67 lei
-5% Nou
Puncte Express: 1020
Preț estimativ în valută:
130.11€ • 134.23$ • 110.12£
130.11€ • 134.23$ • 110.12£
Carte tipărită la comandă
Livrare economică 04-18 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780470414118
ISBN-10: 0470414111
Pagini: 320
Dimensiuni: 156 x 234 x 18 mm
Greutate: 0.61 kg
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 0470414111
Pagini: 320
Dimensiuni: 156 x 234 x 18 mm
Greutate: 0.61 kg
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Medicinal chemists who need to understand basic principles of enzyme kinetics so they are better able to interpret SAR data, scientists, senior scientists and directors in screening and biochemistry departments of biotech and pharmaceutical companies, biochemists, enzymologists, and molecular biologists, graduate students in medicinal chemistry, enzymology, metabolism and pharmacology, and pharma / drug related programs.Cuprins
Notă biografică
ROSS L. STEIN received his PhD in physical organic chemistry from Indiana University in 1978, after which he conducted post-doctoral research in mechanistic enzymology at the University of Kansas. His career has included positions at Merck, where he headed the Enzymology Department, and ProScript (acquired by Millennium in 1999) as vice president of biochemistry. At ProScript, Dr. Stein was instrumental in the pre-clinical development and co-inventor of the drug VELCADETM, a proteasome inhibitor used to treat multiple myeloma. In 2001, he accepted a position at Harvard Medical School to establish and head the Laboratory for Drug Discovery in Neurodegeneration. Most recently, from 2009-2011, Dr. Stein was vice president of drug discovery at Sirtris Pharmaceuticals.
Descriere
Few scientists have the knowledge to perform the studies that are necessary to discover and characterize enzyme inhibitors, despite the vested interest the pharmaceutical industry has in this field.